HBK Investments’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-6,390
Closed -$335K – 1275
2018
Q4
$335K Sell
6,390
-8,367
-57% -$476K ﹤0.01% 1008
2018
Q3
$853K Sell
14,757
-11,752
-44% -$659K 0.01% 780
2018
Q2
$1.51M Buy
26,509
+14,058
+113% +$800K 0.01% 543
2018
Q1
$732K Buy
12,451
+3,767
+43% +$211K 0.01% 687
2017
Q4
$475K Buy
8,684
+3,284
+61% +$170K ﹤0.01% 756
2017
Q3
$255K Buy
+5,400
New +$254K ﹤0.01% 913
2017
Q2
– Sell
-47,008
Closed -$1.79M – 992
2017
Q1
$1.79M Buy
47,008
+608
+1% +$22.5K 0.01% 340
2016
Q4
$1.68M Buy
46,400
+21,200
+84% +$805K 0.02% 377
2016
Q3
$1.08M Buy
25,200
+12,600
+100% +$562K 0.01% 498
2016
Q2
$534K Buy
+12,600
New +$548K ﹤0.01% 715

Other funds holding OFIX

HBK Investments's OFIX Position: Q1 2019 in Review

HBK Investments sold out of Orthofix Medical (OFIX) in Q1 2019, closing a stake of 6,390 shares — an estimated $335K sold.

HBK Investments first reported a position in OFIX in Q2 2016 and held it in 10 quarters. The position peaked at $1.79M in Q1 2017. 172 funds tracked by Wall St. Rank hold OFIX as of Q1 2019.

  • HBK Investments reported no remaining Orthofix Medical position as of Q1 2019 after selling out during the quarter.
  • HBK Investments sold 6,390 Orthofix Medical shares in Q1 2019, an estimated $335K.
  • HBK Investments first reported a position in Orthofix Medical in Q2 2016 and held it in 10 quarters.
  • HBK Investments's Orthofix Medical position peaked at $1.79M in Q1 2017.
  • 172 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2019.

Based on HBK Investments's 13F filing for Q1 2019, filed 15 May 2019.